Endothelial Dysfunction and Altered Endothelial Biomarkers in Patients with Post-COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS)

Overview

Journal J Transl Med

Publisher Biomed Central

Specialties Biomedical Engineering
General Medicine

Date 2022 Mar 23

PMID 35317812

Authors

Milan Haffke

Helma Freitag

Gordon Rudolf

Martina Seifert

Wolfram Doehner

Nadja Scherbakov

Leif Hanitsch

Kirsten Wittke

Sandra Bauer

Frank Konietschke

Friedemann Paul

Judith Bellmann-Strobl

Claudia Kedor

Carmen Scheibenbogen

Franziska Sotzny

Affiliations

Soon will be listed here.

Abstract

Background: Fatigue, exertion intolerance and post-exertional malaise are among the most frequent symptoms of Post-COVID Syndrome (PCS), with a subset of patients fulfilling criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). As SARS-CoV-2 infects endothelial cells, causing endotheliitis and damaging the endothelium, we investigated endothelial dysfunction (ED) and endothelial biomarkers in patients with PCS.

Methods: We studied the endothelial function in 30 PCS patients with persistent fatigue and exertion intolerance as well as in 15 age- and sex matched seronegative healthy controls (HCs). 14 patients fulfilled the diagnostic criteria for ME/CFS. The other patients were considered to have PCS. Peripheral endothelial function was assessed by the reactive hyperaemia index (RHI) using peripheral arterial tonometry (PAT) in patients and HCs. In a larger cohort of patients and HCs, including post-COVID reconvalescents (PCHCs), Endothelin-1 (ET-1), Angiopoietin-2 (Ang-2), Endocan (ESM-1), IL-8, Angiotensin-Converting Enzyme (ACE) and ACE2 were analysed as endothelial biomarkers.

Results: Five of the 14 post-COVID ME/CFS patients and five of the 16 PCS patients showed ED defined by a diminished RHI (< 1.67), but none of HCs exhibited this finding. A paradoxical positive correlation of RHI with age, blood pressure and BMI was found in PCS but not ME/CFS patients. The ET-1 concentration was significantly elevated in both ME/CFS and PCS patients compared to HCs and PCHCs. The serum Ang-2 concentration was lower in both PCS patients and PCHCs compared to HCs.

Conclusion: A subset of PCS patients display evidence for ED shown by a diminished RHI and altered endothelial biomarkers. Different associations of the RHI with clinical parameters as well as varying biomarker profiles may suggest distinct pathomechanisms among patient subgroups.

Citing Articles

NETosis: A key player in autoimmunity, COVID-19, and long COVID.

Monsalve D, Acosta-Ampudia Y, Acosta N, Celis-Andrade M, Sahin A, Yilmaz A J Transl Autoimmun. 2025; 10:100280.

PMID: 40071133 PMC: 11894324. DOI: 10.1016/j.jtauto.2025.100280.

Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFS.

Fehrer A, Sotzny F, Kim L, Kedor C, Freitag H, Heindrich C J Clin Med. 2025; 14(4).

PMID: 40004616 PMC: 11856657. DOI: 10.3390/jcm14041086.

Demographic, epidemiological and clinical profile of patients with post-COVID syndrome followed at a teaching hospital in Brazil.

Melo J, Silva A, Yamamoto L, Ferreira T, Luvizutto G, Neves F Braz J Infect Dis. 2025; 29(2):104509.

PMID: 39978115 PMC: 11889545. DOI: 10.1016/j.bjid.2025.104509.

Prevalence of cardiovascular symptoms in post-acute COVID-19 syndrome: a meta-analysis.

Huang L, Li H, He B, Wang X, Zhang Q, Peng W BMC Med. 2025; 23(1):70.

PMID: 39915795 PMC: 11803987. DOI: 10.1186/s12916-025-03908-3.

Endocan as a marker of endotheliitis in COVID-19 patients: modulation by veno-venous extracorporeal membrane oxygenation, arterial hypertension and previous treatment with renin-angiotensin-aldosterone system inhibitors.

Reina-Couto M, Alves D, Silva-Pereira C, Pereira-Terra P, Martins S, Bessa J Inflamm Res. 2025; 74(1):26.

PMID: 39862311 PMC: 11762693. DOI: 10.1007/s00011-024-01964-8.

References

Davis H, Assaf G, McCorkell L, Wei H, Low R, Reem Y . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021; 38:101019. PMC: 8280690. DOI: 10.1016/j.eclinm.2021.101019. View

Singh I, Joseph P, Heerdt P, Cullinan M, Lutchmansingh D, Gulati M . Persistent Exertional Intolerance After COVID-19: Insights From Invasive Cardiopulmonary Exercise Testing. Chest. 2021; 161(1):54-63. PMC: 8354807. DOI: 10.1016/j.chest.2021.08.010. View

Newton D, Kennedy G, Chan K, Lang C, Belch J, Khan F . Large and small artery endothelial dysfunction in chronic fatigue syndrome. Int J Cardiol. 2011; 154(3):335-6. DOI: 10.1016/j.ijcard.2011.10.030. View

Teuwen L, Geldhof V, Pasut A, Carmeliet P . Author Correction: COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020; 20(7):448. PMC: 7270747. DOI: 10.1038/s41577-020-0356-8. View

Xie Y, Bowe B, Al-Aly Z . Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat Commun. 2021; 12(1):6571. PMC: 8589966. DOI: 10.1038/s41467-021-26513-3. View

Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

Novitzky-Basso I, Rot A . Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines. Front Immunol. 2012; 3:266. PMC: 3421148. DOI: 10.3389/fimmu.2012.00266. View

Wirth K, Scheibenbogen C, Paul F . An attempt to explain the neurological symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. J Transl Med. 2021; 19(1):471. PMC: 8607226. DOI: 10.1186/s12967-021-03143-3. View

Jason L, Sunnquist M, Brown A, Reed J . Defining Essential Features of Myalgic Encephalomyelitis and Chronic Fatigue Syndrome. J Hum Behav Soc Environ. 2016; 25(6):657-674. PMC: 4817848. DOI: 10.1080/10911359.2015.1011256. View

10.

Chu L, Valencia I, Garvert D, Montoya J . Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Pediatr. 2019; 7:12. PMC: 6370741. DOI: 10.3389/fped.2019.00012. View

11.

Rafnsson A, Bohm F, Settergren M, Gonon A, Brismar K, Pernow J . The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. Diabetologia. 2011; 55(3):600-7. DOI: 10.1007/s00125-011-2415-y. View

12.

Huertas A, Montani D, Savale L, Pichon J, Tu L, Parent F . Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?. Eur Respir J. 2020; 56(1). PMC: 7301835. DOI: 10.1183/13993003.01634-2020. View

13.

Yu H, Huang X, Ma Y, Gao M, Wang O, Gao T . Interleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions. Int J Biol Sci. 2013; 9(9):966-79. PMC: 3805902. DOI: 10.7150/ijbs.6996. View

14.

Oude Nijhuis C, Vellenga E, Daenen S, Kamps W, de Bont E . Endothelial cells are main producers of interleukin 8 through Toll-like receptor 2 and 4 signaling during bacterial infection in leukopenic cancer patients. Clin Diagn Lab Immunol. 2003; 10(4):558-63. PMC: 164273. DOI: 10.1128/cdli.10.4.558-563.2003. View

15.

Li L, Li J, Gao M, Fan H, Wang Y, Xu X . Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients. Front Immunol. 2021; 11:602395. PMC: 7820901. DOI: 10.3389/fimmu.2020.602395. View

16.

Jackson C . The Chalder Fatigue Scale (CFQ 11). Occup Med (Lond). 2015; 65(1):86. DOI: 10.1093/occmed/kqu168. View

17.

Zanoli L, Briet M, Empana J, Cunha P, Maki-Petaja K, Protogerou A . Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society. J Hypertens. 2020; 38(9):1682-1698. PMC: 7610698. DOI: 10.1097/HJH.0000000000002508. View

18.

Theofilis P, Sagris M, Oikonomou E, Antonopoulos A, Siasos G, Tsioufis C . Inflammatory Mechanisms Contributing to Endothelial Dysfunction. Biomedicines. 2021; 9(7). PMC: 8301477. DOI: 10.3390/biomedicines9070781. View

19.

Chlench S, Mecha Disassa N, Hohberg M, Hoffmann C, Pohlkamp T, Beyer G . Regulation of Foxo-1 and the angiopoietin-2/Tie2 system by shear stress. FEBS Lett. 2007; 581(4):673-80. DOI: 10.1016/j.febslet.2007.01.028. View

20.

Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F . Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020; 383(2):120-128. PMC: 7412750. DOI: 10.1056/NEJMoa2015432. View